首页 > 最新文献

Pediatric neurology最新文献

英文 中文
Rare Occurrence of Congenital Neuroblastoma and Tuberous Sclerosis 罕见的先天性神经母细胞瘤和结节性硬化症
IF 2.1 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2025-12-31 DOI: 10.1016/j.pediatrneurol.2025.12.018
Madeline Gardner BSc, MD , Snehal Shah MD, MBBS, DNB , Neha Jain MBBS, DCH, MPH , Michael Bynevelt BHB, MBChB
{"title":"Rare Occurrence of Congenital Neuroblastoma and Tuberous Sclerosis","authors":"Madeline Gardner BSc, MD , Snehal Shah MD, MBBS, DNB , Neha Jain MBBS, DCH, MPH , Michael Bynevelt BHB, MBChB","doi":"10.1016/j.pediatrneurol.2025.12.018","DOIUrl":"10.1016/j.pediatrneurol.2025.12.018","url":null,"abstract":"","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"176 ","pages":"Pages 62-63"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145979141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Era of Gene Therapy, Newborn Screening, and Improved Management in the Leukodystrophies: A Shifting Framework With Altered Expectations 基因治疗、新生儿筛查和改善脑白质营养不良管理的时代:一个改变期望的转变框架。
IF 2.1 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2025-12-15 DOI: 10.1016/j.pediatrneurol.2025.12.006
Amanda Nagy MD, Robert Thompson MD, Florian Eichler MD
The field of leukodystrophies (LDs) has undergone a paradigm shift in recent decades. Several factors underlie this change: newborn screening, advanced genetic and metabolic testing, improved understanding and medical management of disease, and targeted therapies addressing underlying molecular etiologies. Recent trials as well as regulatory approvals are testimony to the transformative effects of gene therapy. However, the risks of these treatments remain incompletely understood and include malignancies/premalignancies, immune-mediated hepatic injury, and thrombotic microangiopathy, among others. The implementation of newborn screening for individual LDs allows for improved monitoring and earlier treatment but also extends the measured lifespan following diagnosis, skewing survival data compared to historical data based on symptomatic diagnosis. Lastly, population screening leads to identification of genetic variants with milder or uncertain pathogenicity. In this article, we review the shifting framework impacting life expectancy and decision-making in the LDs along with the risks and uncertainties that have arisen in the setting of recent advancements.
近几十年来,脑白质营养不良(ld)领域经历了范式转变。这一变化背后有几个因素:新生儿筛查、先进的遗传和代谢检测、对疾病的更好理解和医疗管理,以及针对潜在分子病因的靶向治疗。最近的试验以及监管部门的批准都证明了基因疗法的变革性影响。然而,这些治疗的风险仍然不完全清楚,包括恶性肿瘤/恶性前肿瘤、免疫介导的肝损伤和血栓性微血管病等。对个体lld实施新生儿筛查可以改善监测和早期治疗,但也延长了诊断后的测量寿命,使生存数据与基于症状诊断的历史数据相比较。最后,群体筛查可以鉴定出致病性较轻或不确定的遗传变异。在本文中,我们回顾了影响最不发达国家预期寿命和决策的变化框架,以及在最近进展的背景下出现的风险和不确定性。
{"title":"The Era of Gene Therapy, Newborn Screening, and Improved Management in the Leukodystrophies: A Shifting Framework With Altered Expectations","authors":"Amanda Nagy MD,&nbsp;Robert Thompson MD,&nbsp;Florian Eichler MD","doi":"10.1016/j.pediatrneurol.2025.12.006","DOIUrl":"10.1016/j.pediatrneurol.2025.12.006","url":null,"abstract":"<div><div>The field of leukodystrophies (LDs) has undergone a paradigm shift in recent decades. Several factors underlie this change: newborn screening, advanced genetic and metabolic testing, improved understanding and medical management of disease, and targeted therapies addressing underlying molecular etiologies. Recent trials as well as regulatory approvals are testimony to the transformative effects of gene therapy. However, the risks of these treatments remain incompletely understood and include malignancies/premalignancies, immune-mediated hepatic injury, and thrombotic microangiopathy, among others. The implementation of newborn screening for individual LDs allows for improved monitoring and earlier treatment but also extends the measured lifespan following diagnosis, skewing survival data compared to historical data based on symptomatic diagnosis. Lastly, population screening leads to identification of genetic variants with milder or uncertain pathogenicity. In this article, we review the shifting framework impacting life expectancy and decision-making in the LDs along with the risks and uncertainties that have arisen in the setting of recent advancements.</div></div>","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"176 ","pages":"Pages 3-7"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145878778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Lack of Broad Multidisciplinary Assessments in Children and Adolescents With Newly Diagnosed Idiopathic Intracranial Hypertension 新诊断的特发性颅内高压的儿童和青少年缺乏广泛的多学科评估
IF 2.1 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-02 DOI: 10.1016/j.pediatrneurol.2025.12.016
Christoffer Ehrstedt MD, PhD , Gunnar Liminga MD, PhD , Ylva Fredriksson Kaul PhD , Olga Kochukhova PhD , Eva Larsson MD, PhD , Ingela Kristiansen MD, PhD

Background

In pediatric idiopathic intracranial hypertension (IIH) patients, 27-62% have been reported to have difficulties in one or more neurocognitive domains. Also higher rates of mental health issues have been reported, further underscoring the importance of evaluating broader support needs. We aimed to investigate to what extent children and adolescents with newly diagnosed IIH received broad multidisciplinary assessments, as well as educational and weight-management support.

Methods

A population-based single center cohort study, included patients younger than 18 years of age when diagnosed with IIH according to the Friedman criteria, during 2000-2020. A cross-sectional interview survey and retrospective chart review were performed to investigate the frequency of broad multidisciplinary assessments at IIH diagnosis and need of educational support.

Results

Interviews were conducted with 61% (28 of 46) identified patients. According to medical records (N = 46), assessments were conducted by a psychologist in 7%, a physiotherapist in 4%, a social worker in 4%, and a special education teacher in 0%. Among patients with overweight or obesity, 67% were referred to a dietitian for weight management support. Dietitian involvement was more likely in obese than overweight patients, 86% versus 38% (P = 0.04). In addition, 64% of the interviewed patients reported a need for educational support, of whom half (32%) did not receive adequate support in school.

Conclusions

Broad multidisciplinary assessments were uncommon among pediatric patients diagnosed with IIH. There was a high unmet need for educational support. Routine monitoring for neurocognitive impairments and educational needs should be part of pediatric IIH management. A broad multidisciplinary approach would best meet this need.
背景:在儿童特发性颅内高压(IIH)患者中,27-62%的患者在一个或多个神经认知领域存在困难。此外,据报告心理健康问题发生率较高,这进一步强调了评估更广泛的支持需求的重要性。我们的目的是调查新诊断为IIH的儿童和青少年在多大程度上接受了广泛的多学科评估,以及教育和体重管理支持。方法一项基于人群的单中心队列研究,纳入2000-2020年期间根据Friedman标准诊断为IIH的年龄小于18岁的患者。通过横断面访谈调查和回顾性图表回顾来调查IIH诊断中广泛多学科评估的频率和对教育支持的需求。结果对确定的患者进行了61%(46例中28例)的访谈。根据医疗记录(N = 46),由心理学家进行评估的占7%,物理治疗师占4%,社会工作者占4%,特殊教育教师占0%。在超重或肥胖的患者中,67%的人被转介给营养师以获得体重管理支持。肥胖患者比超重患者更有可能参与营养师,86%比38% (P = 0.04)。此外,64%的受访患者报告需要教育支持,其中一半(32%)在学校没有得到足够的支持。结论广泛的多学科评估在诊断为IIH的儿科患者中并不常见。对教育支持的需求未得到充分满足。对神经认知障碍和教育需求的常规监测应成为儿童IIH管理的一部分。广泛的多学科方法最能满足这一需要。
{"title":"The Lack of Broad Multidisciplinary Assessments in Children and Adolescents With Newly Diagnosed Idiopathic Intracranial Hypertension","authors":"Christoffer Ehrstedt MD, PhD ,&nbsp;Gunnar Liminga MD, PhD ,&nbsp;Ylva Fredriksson Kaul PhD ,&nbsp;Olga Kochukhova PhD ,&nbsp;Eva Larsson MD, PhD ,&nbsp;Ingela Kristiansen MD, PhD","doi":"10.1016/j.pediatrneurol.2025.12.016","DOIUrl":"10.1016/j.pediatrneurol.2025.12.016","url":null,"abstract":"<div><h3>Background</h3><div>In pediatric idiopathic intracranial hypertension (IIH) patients, 27-62% have been reported to have difficulties in one or more neurocognitive domains. Also higher rates of mental health issues have been reported, further underscoring the importance of evaluating broader support needs. We aimed to investigate to what extent children and adolescents with newly diagnosed IIH received broad multidisciplinary assessments, as well as educational and weight-management support.</div></div><div><h3>Methods</h3><div>A population-based single center cohort study, included patients younger than 18 years of age when diagnosed with IIH according to the Friedman criteria, during 2000-2020. A cross-sectional interview survey and retrospective chart review were performed to investigate the frequency of broad multidisciplinary assessments at IIH diagnosis and need of educational support.</div></div><div><h3>Results</h3><div>Interviews were conducted with 61% (28 of 46) identified patients. According to medical records (N = 46), assessments were conducted by a psychologist in 7%, a physiotherapist in 4%, a social worker in 4%, and a special education teacher in 0%. Among patients with overweight or obesity, 67% were referred to a dietitian for weight management support. Dietitian involvement was more likely in obese than overweight patients, 86% versus 38% (<em>P</em> = 0.04). In addition, 64% of the interviewed patients reported a need for educational support, of whom half (32%) did not receive adequate support in school.</div></div><div><h3>Conclusions</h3><div>Broad multidisciplinary assessments were uncommon among pediatric patients diagnosed with IIH. There was a high unmet need for educational support. Routine monitoring for neurocognitive impairments and educational needs should be part of pediatric IIH management. A broad multidisciplinary approach would best meet this need.</div></div>","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"176 ","pages":"Pages 134-140"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Decade of Changes: Investigating Etiologies in Epileptic Spasms 十年的变化:调查癫痫痉挛的病因
IF 2.1 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-09 DOI: 10.1016/j.pediatrneurol.2025.12.028
Lucia Fusco MD, PhD , Nicola Specchio MD, PhD
{"title":"A Decade of Changes: Investigating Etiologies in Epileptic Spasms","authors":"Lucia Fusco MD, PhD ,&nbsp;Nicola Specchio MD, PhD","doi":"10.1016/j.pediatrneurol.2025.12.028","DOIUrl":"10.1016/j.pediatrneurol.2025.12.028","url":null,"abstract":"","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"176 ","pages":"Pages 89-91"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146023252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Educational and Social Outcomes in Optic Nerve Hypoplasia and Septo-Optic-Pituitary Dysplasia 视神经发育不全和中隔-视垂体发育不良的教育和社会结果
IF 2.1 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2025-12-31 DOI: 10.1016/j.pediatrneurol.2025.12.019
Michael S. Salman MBBS, BSc, MSc, PhD , Chelsea A. Ruth MD, MSc, FRCPC , Randy Walld BSc, BComm (Hons) , Marina S. Yogendran MSc , Lisa M. Lix PhD

Background

To describe educational and social outcomes in optic nerve hypoplasia/septo-optic-pituitary dysplasia (ONH/SOD) in Manitoba, Canada.

Methods

A population-based case-control study used administrative health, education, and social data from the Manitoba Population Research Data Repository. A total of 124 ONH/SOD patients diagnosed during 1990-2019 were matched to 620 unrelated population-based controls on area of residence, birth year, and sex. Multivariable logistic regression tested for differences between cases and controls on selected educational and social outcomes. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated.

Results

Cases had higher odds than controls for requiring specialized educational funding (OR: 13.12, 95% CI: 7.06-24.40). Vulnerability in any five domains of Early Development Instrument, a measure of school readiness, showed higher odds in cases (OR: 2.58, 95% CI: 1.09-6.10). In addition, cases had higher odds of contact with Child and Family Services (OR: 1.81, 95% CI: 1.22-2.69), and being taken into care at any time after birth (OR: 2.10, 95% CI: 1.32-3.35).

Conclusions

Cases with ONH/SOD had a need for greater resources and more adverse educational and social outcomes. It is recommended for social and educational service providers to work together with health care providers to ensure appropriate supports are in place for cases with ONH/SOD.
背景:描述加拿大马尼托巴省视神经发育不全/中隔-视垂体发育不良(ONH/SOD)的教育和社会结果。方法一项基于人群的病例对照研究使用了马尼托巴人口研究数据库中的行政卫生、教育和社会数据。在1990-2019年期间诊断的124名ONH/SOD患者与620名不相关的基于人口的对照者在居住地区、出生年份和性别方面进行了匹配。多变量逻辑回归检验了病例和对照组在选定的教育和社会结果上的差异。估计95%置信区间(ci)的优势比(ORs)。结果病例需要专项教育经费的几率高于对照组(OR: 13.12, 95% CI: 7.06 ~ 24.40)。早期发展工具(一种衡量入学准备程度的方法)中任何五个领域的脆弱性都显示出较高的几率(OR: 2.58, 95% CI: 1.09-6.10)。此外,病例与儿童和家庭服务机构接触的几率更高(OR: 1.81, 95% CI: 1.22-2.69),出生后任何时候得到照顾的几率更高(OR: 2.10, 95% CI: 1.32-3.35)。结论ONH/SOD患者需要更多的资源,并有更多的不良教育和社会结果。建议社会和教育服务提供者与卫生保健提供者共同努力,确保为ONH/SOD病例提供适当的支持。
{"title":"Educational and Social Outcomes in Optic Nerve Hypoplasia and Septo-Optic-Pituitary Dysplasia","authors":"Michael S. Salman MBBS, BSc, MSc, PhD ,&nbsp;Chelsea A. Ruth MD, MSc, FRCPC ,&nbsp;Randy Walld BSc, BComm (Hons) ,&nbsp;Marina S. Yogendran MSc ,&nbsp;Lisa M. Lix PhD","doi":"10.1016/j.pediatrneurol.2025.12.019","DOIUrl":"10.1016/j.pediatrneurol.2025.12.019","url":null,"abstract":"<div><h3>Background</h3><div>To describe educational and social outcomes in optic nerve hypoplasia/septo-optic-pituitary dysplasia (ONH/SOD) in Manitoba, Canada.</div></div><div><h3>Methods</h3><div>A population-based case-control study used administrative health, education, and social data from the Manitoba Population Research Data Repository. A total of 124 ONH/SOD patients diagnosed during 1990-2019 were matched to 620 unrelated population-based controls on area of residence, birth year, and sex. Multivariable logistic regression tested for differences between cases and controls on selected educational and social outcomes. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated.</div></div><div><h3>Results</h3><div>Cases had higher odds than controls for requiring specialized educational funding (OR: 13.12, 95% CI: 7.06-24.40). Vulnerability in any five domains of Early Development Instrument, a measure of school readiness, showed higher odds in cases (OR: 2.58, 95% CI: 1.09-6.10). In addition, cases had higher odds of contact with Child and Family Services (OR: 1.81, 95% CI: 1.22-2.69), and being taken into care at any time after birth (OR: 2.10, 95% CI: 1.32-3.35).</div></div><div><h3>Conclusions</h3><div>Cases with ONH/SOD had a need for greater resources and more adverse educational and social outcomes. It is recommended for social and educational service providers to work together with health care providers to ensure appropriate supports are in place for cases with ONH/SOD.</div></div>","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"176 ","pages":"Pages 77-85"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145978544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurocognitive Outcome After Pediatric Traumatic Brain Injury: Patient Subgroups With Diverging Outcome 儿童创伤性脑损伤后的神经认知结果:结果不同的患者亚组
IF 2.1 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-02 DOI: 10.1016/j.pediatrneurol.2025.12.020
Cece C. Kooper , Marsh Königs PhD , Marjan E. Steenweg PhD , Maayke Hunfeld MD, PhD , Nienke C.D. Scheurer MD , Herman M. Schippers MD , Willy Peper MD , Arne Popma MD, PhD , Job B.M. van Woensel MD, PhD , Dennis R. Buis MD, PhD , Hilgo Bruining MD, PhD , Marc Engelen MD, PhD , Jaap Oosterlaan MD, PhD

Background

To investigate whether the heterogeneity in neurocognitive outcome following pediatric traumatic brain injury (TBI) can be reduced by distinguishing subgroups of children with distinct profiles of neurocognitive functioning, and to investigate whether these subgroups differ in demographic, premorbid, and clinical characteristics.

Methods

In this multicenter study, 113 children with TBI (mild [82%], moderate [7%], severe [11%]) and 113 demographically matched neurologically healthy (NH) children were assessed using comprehensive computerized neurocognitive testing at 6 months post-TBI. The TBI and NH groups were compared on neurocognitive domains, and the TBI group was subjected to cluster analysis to identify neurocognitive subgroups. Resulting subgroups were compared on demographic, premorbid, and clinical characteristics.

Results

Children with TBI had lower performance than NH children in Speed, Stability, Attention & Control, Verbal Working Memory, and Visual Working Memory (P < 0.05, d ≤ −0.42, small effect sizes). Cluster analysis identified four distinct subgroups: one had good outcome and three had adverse outcomes characterized by weak global outcome, weak visual-processing outcome, or weak executive functioning outcome. While subgroups did not differ in clinical characteristics including TBI severity, the weak global outcome subgroup had more premorbid behavioral problems, and the good outcome subgroup had higher socioeconomic status.

Conclusions

This study indicates that children with mild to severe TBI exhibit neurocognitive deficits at 6 months post-TBI, among which subgroups of children with distinct neurocognitive outcome profiles exist. The neurocognitive outcome subgroups represent children with diverging severity and configuration of neurocognitive weaknesses. Clinical characteristics were not related to the outcome subgroups, highlighting the importance to consider other factors for the prognosis of neurocognitive outcome.
研究是否可以通过区分具有不同神经认知功能的儿童亚组来减少小儿创伤性脑损伤(TBI)后神经认知结果的异质性,并研究这些亚组在人口学、发病前和临床特征方面是否存在差异。方法在这项多中心研究中,113名TBI儿童(轻度[82%],中度[7%],重度[11%])和113名人口统计学匹配的神经健康(NH)儿童在TBI后6个月采用综合计算机化神经认知测试进行评估。比较TBI组和NH组在神经认知领域的差异,并对TBI组进行聚类分析以确定神经认知亚群。结果亚组在人口学、发病前和临床特征上进行比较。结果创伤性脑损伤儿童在速度、稳定性、注意控制、言语工作记忆和视觉工作记忆方面的表现低于正常儿童(P < 0.05, d≤- 0.42,效应量小)。聚类分析确定了四个不同的亚组:一个有良好的结果,三个有不良的结果,其特征是整体结果较弱,视觉处理结果较弱,或执行功能结果较弱。虽然亚组在包括TBI严重程度在内的临床特征上没有差异,但整体结果较弱的亚组有更多的病前行为问题,而结果较好的亚组有更高的社会经济地位。结论本研究提示,轻度至重度脑损伤儿童在脑损伤后6个月表现出神经认知缺陷,其中存在具有不同神经认知结局特征的儿童亚群。神经认知结果亚组代表了神经认知缺陷严重程度和配置不同的儿童。临床特征与预后亚组无关,强调了考虑其他因素对神经认知预后的重要性。
{"title":"Neurocognitive Outcome After Pediatric Traumatic Brain Injury: Patient Subgroups With Diverging Outcome","authors":"Cece C. Kooper ,&nbsp;Marsh Königs PhD ,&nbsp;Marjan E. Steenweg PhD ,&nbsp;Maayke Hunfeld MD, PhD ,&nbsp;Nienke C.D. Scheurer MD ,&nbsp;Herman M. Schippers MD ,&nbsp;Willy Peper MD ,&nbsp;Arne Popma MD, PhD ,&nbsp;Job B.M. van Woensel MD, PhD ,&nbsp;Dennis R. Buis MD, PhD ,&nbsp;Hilgo Bruining MD, PhD ,&nbsp;Marc Engelen MD, PhD ,&nbsp;Jaap Oosterlaan MD, PhD","doi":"10.1016/j.pediatrneurol.2025.12.020","DOIUrl":"10.1016/j.pediatrneurol.2025.12.020","url":null,"abstract":"<div><h3>Background</h3><div>To investigate whether the heterogeneity in neurocognitive outcome following pediatric traumatic brain injury (TBI) can be reduced by distinguishing subgroups of children with distinct profiles of neurocognitive functioning, and to investigate whether these subgroups differ in demographic, premorbid, and clinical characteristics.</div></div><div><h3>Methods</h3><div>In this multicenter study, 113 children with TBI (mild [82%], moderate [7%], severe [11%]) and 113 demographically matched neurologically healthy (NH) children were assessed using comprehensive computerized neurocognitive testing at 6 months post-TBI. The TBI and NH groups were compared on neurocognitive domains, and the TBI group was subjected to cluster analysis to identify neurocognitive subgroups. Resulting subgroups were compared on demographic, premorbid, and clinical characteristics.</div></div><div><h3>Results</h3><div>Children with TBI had lower performance than NH children in Speed, Stability, Attention &amp; Control, Verbal Working Memory, and Visual Working Memory (<em>P</em> &lt; 0.05, <em>d</em> ≤ −0.42, small effect sizes). Cluster analysis identified four distinct subgroups: one had good outcome and three had adverse outcomes characterized by weak global outcome, weak visual-processing outcome, or weak executive functioning outcome. While subgroups did not differ in clinical characteristics including TBI severity, the weak global outcome subgroup had more premorbid behavioral problems, and the good outcome subgroup had higher socioeconomic status.</div></div><div><h3>Conclusions</h3><div>This study indicates that children with mild to severe TBI exhibit neurocognitive deficits at 6 months post-TBI, among which subgroups of children with distinct neurocognitive outcome profiles exist. The neurocognitive outcome subgroups represent children with diverging severity and configuration of neurocognitive weaknesses. Clinical characteristics were not related to the outcome subgroups, highlighting the importance to consider other factors for the prognosis of neurocognitive outcome.</div></div>","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"176 ","pages":"Pages 103-111"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146023387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumefactive Demyelination in a Child With IKZF1 Gain-of-Function Variant IKZF1功能获得变异儿童的肿瘤性脱髓鞘
IF 2.1 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-14 DOI: 10.1016/j.pediatrneurol.2026.01.006
Tiffany Vuong BA , Maeve C. Lucas BS , Mariam M. Yousuf BS , Samuel T. Otey BS , Abhik K. Banerjee MD, PhD , Jonathan D. Santoro MD
{"title":"Tumefactive Demyelination in a Child With IKZF1 Gain-of-Function Variant","authors":"Tiffany Vuong BA ,&nbsp;Maeve C. Lucas BS ,&nbsp;Mariam M. Yousuf BS ,&nbsp;Samuel T. Otey BS ,&nbsp;Abhik K. Banerjee MD, PhD ,&nbsp;Jonathan D. Santoro MD","doi":"10.1016/j.pediatrneurol.2026.01.006","DOIUrl":"10.1016/j.pediatrneurol.2026.01.006","url":null,"abstract":"","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"176 ","pages":"Pages 141-144"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Predrug Resistant Versus Postdrug Resistant Surgery in Children With Focal Cortical Dysplasia–Related Epilepsy: Drug Resistance Should Not Be the Threshold for Surgical Candidacy 局灶性皮质发育不良相关癫痫患儿耐药前与耐药后手术的结果:耐药不应成为手术候选的门槛
IF 2.1 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-06 DOI: 10.1016/j.pediatrneurol.2025.12.026
Yuxin Wu PhD , Zaiyu Zhang PhD , Ping Liang PhD , Lusheng Li PhD , Bin Zou MSc , Xuanxuan Wu PhD , Difei Wang MSc , Xinyu Dong MSc , Hanli Qiu MSc , Haotian Tang MSc , Kaiyi Kang MSc , Xuan Zhai PhD

Background

Surgical intervention has become an established treatment option for epilepsy, but its traditional indications are limited to drug resistant cases. This study compares outcomes of early surgery (predrug resistance) with traditional surgery (postdrug resistance) in focal cortical dysplasia (FCD)-related epilepsy, providing clinical evidence for early surgical intervention.

Methods

Medical records of FCD-related epilepsy children who underwent 1.5 T or 3T brain magnetic resonance imaging at our center (Jan 2008-Dec 2022) were reviewed. Children were divided into early surgery and traditional surgery groups based on treatment pathway. Postoperative seizure outcomes, antiseizure medication (ASM) outcomes, seizure duration, and ASM usage were compared.

Results

Of the 195 children with magnetic resonance imaging–confirmed FCD who met the inclusion criteria, 167 (85.6%) were diagnosed with FCD-related epilepsy. Median follow-up duration was 61 months. Twenty-eight (16.7%) achieved seizure freedom with the first ASM, while 5.6% and 5.4% achieved seizure freedom with the second and third or more ASMs, respectively. Ninety-nine children received surgical treatment, with 45 undergoing early surgery and 54 receiving traditional surgery. At the last follow-up, significantly more children in the early surgery group (88.9%) achieved seizure freedom compared to the traditional surgery group (74.1%) (P = 0.033).

Conclusions

Early surgical evaluation can help identify candidates who may benefit from early surgery while maintaining comparable perioperative risks to traditional surgery. Therefore, it is necessary to refine the timing and criteria for epilepsy surgery evaluation. For patients with noneloquent cortical brain lesions, early surgery is recommended to reduce the duration of living with seizure.
手术干预已成为癫痫的一种既定治疗选择,但其传统适应症仅限于耐药病例。本研究比较局灶性皮质发育不良(FCD)相关癫痫早期手术(耐药前)与传统手术(耐药后)的治疗效果,为早期手术干预提供临床依据。方法回顾2008年1月至2022年12月在我中心接受1.5 T或3T脑磁共振成像的fcd相关癫痫患儿的病历。根据治疗途径将患儿分为早期手术组和传统手术组。比较术后癫痫发作结果、抗癫痫药物(ASM)结果、癫痫发作持续时间和ASM使用情况。结果符合纳入标准的195例FCD患儿中,167例(85.6%)被诊断为FCD相关癫痫。中位随访时间为61个月。28例患者(16.7%)在第一次ASM中获得癫痫发作自由,而在第二次和第三次或更多ASM中分别获得5.6%和5.4%的癫痫发作自由。手术治疗99例,早期手术45例,传统手术54例。末次随访时,早期手术组患儿癫痫发作自由率(88.9%)明显高于传统手术组(74.1%),差异有统计学意义(P = 0.033)。结论早期手术评估可以帮助确定可能从早期手术中获益的候选人,同时保持与传统手术相当的围手术期风险。因此,有必要完善癫痫手术评估的时机和标准。对于患有非显性脑皮质病变的患者,建议早期手术以减少癫痫发作的持续时间。
{"title":"Outcomes of Predrug Resistant Versus Postdrug Resistant Surgery in Children With Focal Cortical Dysplasia–Related Epilepsy: Drug Resistance Should Not Be the Threshold for Surgical Candidacy","authors":"Yuxin Wu PhD ,&nbsp;Zaiyu Zhang PhD ,&nbsp;Ping Liang PhD ,&nbsp;Lusheng Li PhD ,&nbsp;Bin Zou MSc ,&nbsp;Xuanxuan Wu PhD ,&nbsp;Difei Wang MSc ,&nbsp;Xinyu Dong MSc ,&nbsp;Hanli Qiu MSc ,&nbsp;Haotian Tang MSc ,&nbsp;Kaiyi Kang MSc ,&nbsp;Xuan Zhai PhD","doi":"10.1016/j.pediatrneurol.2025.12.026","DOIUrl":"10.1016/j.pediatrneurol.2025.12.026","url":null,"abstract":"<div><h3>Background</h3><div>Surgical intervention has become an established treatment option for epilepsy, but its traditional indications are limited to drug resistant cases. This study compares outcomes of early surgery (predrug resistance) with traditional surgery (postdrug resistance) in focal cortical dysplasia (FCD)-related epilepsy, providing clinical evidence for early surgical intervention.</div></div><div><h3>Methods</h3><div>Medical records of FCD-related epilepsy children who underwent 1.5 T or 3T brain magnetic resonance imaging at our center (Jan 2008-Dec 2022) were reviewed. Children were divided into early surgery and traditional surgery groups based on treatment pathway. Postoperative seizure outcomes, antiseizure medication (ASM) outcomes, seizure duration, and ASM usage were compared.</div></div><div><h3>Results</h3><div>Of the 195 children with magnetic resonance imaging–confirmed FCD who met the inclusion criteria, 167 (85.6%) were diagnosed with FCD-related epilepsy. Median follow-up duration was 61 months. Twenty-eight (16.7%) achieved seizure freedom with the first ASM, while 5.6% and 5.4% achieved seizure freedom with the second and third or more ASMs, respectively. Ninety-nine children received surgical treatment, with 45 undergoing early surgery and 54 receiving traditional surgery. At the last follow-up, significantly more children in the early surgery group (88.9%) achieved seizure freedom compared to the traditional surgery group (74.1%) (<em>P</em> = 0.033).</div></div><div><h3>Conclusions</h3><div>Early surgical evaluation can help identify candidates who may benefit from early surgery while maintaining comparable perioperative risks to traditional surgery. Therefore, it is necessary to refine the timing and criteria for epilepsy surgery evaluation. For patients with noneloquent cortical brain lesions, early surgery is recommended to reduce the duration of living with seizure.</div></div>","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"176 ","pages":"Pages 92-102"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146023384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of RNA Polymerase III–Related Leukodystrophy on Nonaffected Family Members: A Qualitative Study RNA聚合酶iii相关的白质营养不良对未受影响的家庭成员的影响:一项定性研究
IF 2.1 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2025-12-16 DOI: 10.1016/j.pediatrneurol.2025.12.004
Adam Le MSc , Kelly-Ann Thibault DEC , Pouneh Amir Yazdani MD , Alexandra Chapleau HBSc , Romy J. van Voorst MSc , Enrico Bertini MD , Francesco Nicita MD, PhD , Daniela Pohl MD, PhD , Sunita Venkateswaran MD , Stephanie Keller MD , Deborah Renaud MD , Dolores Gonzalez Moron MD, PhD , Marcelo Kauffman MD, MSc, PhD , Danilo De Assis Pereira MD , Adeline Vanderver MD , Marjo S. van der Knaap MD, PhD , Maxime Morsa PhD , Geneviève Bernard MD, MSc, FRCPc

Background

RNA polymerase III–related hypomyelinating leukodystrophy (POLR3-HLD) is a rare, neurodegenerative, brain white matter disorder characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism. Due to the complex and progressive nature of this disorder, parents and siblings of patients face many potential challenges and stressors. We, therefore, sought to explore parents' and siblings’ experiences to understand their specific needs and identify modifiable factors to limit familial burden and improve their quality of life.

Methods

We conducted semistructured interviews with parents and siblings of patients with POLR3-HLD. Interview questions focused on the financial, emotional, and psychosocial impacts on parents, as well as siblings’ relationship with their affected sibling and the psychosocial impacts they may have experienced. All interviews were recorded, transcribed, and analyzed using reflexive thematic analysis. Through the coding process, themes surrounding the impact on and experiences of parents and siblings were developed.

Results

Nineteen semistructured interviews with 24 parents and nine interviews with 9 siblings were completed between March and October 2023 and February and May 2024, respectively. Four themes from parent interviews included extensive caregiver burden, emotional and psychosocial challenges, the importance of parental self-health, and comfort in the leukodystrophy community. Three themes from sibling interviews included the spectrum of emotional impacts, limited knowledge about POLR3-HLD, and adapting to their sibling's needs.

Conclusions

This study provides a comprehensive understanding of the family experience, identifying the common challenges and specific needs of parents and siblings, highlighting areas of improvement in the global care offered to this vulnerable patient population.
背景:rna聚合酶iii相关的髓鞘退化性白质营养不良(POLR3-HLD)是一种罕见的神经退行性脑白质疾病,其特征为髓鞘退化、牙髓缺损和促性腺功能减退。由于这种疾病的复杂性和进行性,患者的父母和兄弟姐妹面临许多潜在的挑战和压力源。因此,我们试图探索父母和兄弟姐妹的经历,以了解他们的具体需求,并确定可改变的因素,以减轻家庭负担,提高他们的生活质量。方法对POLR3-HLD患者的父母和兄弟姐妹进行半结构化访谈。访谈问题集中在对父母的经济、情感和社会心理影响,以及兄弟姐妹与受影响兄弟姐妹的关系以及他们可能经历的社会心理影响。所有访谈都被记录、转录,并使用反身性主题分析进行分析。通过编码过程,围绕父母和兄弟姐妹的影响和经历的主题被开发出来。结果于2023年3月至10月和2024年2月至5月分别对24名家长和9名兄弟姐妹进行了19次半结构化访谈。来自父母访谈的四个主题包括广泛的照顾者负担,情感和心理社会挑战,父母自我健康的重要性,以及在白质营养不良社区的安慰。兄弟姐妹访谈的三个主题包括情绪影响的范围,对POLR3-HLD的有限知识,以及适应兄弟姐妹的需求。本研究提供了对家庭经验的全面了解,确定了父母和兄弟姐妹的共同挑战和特殊需求,强调了为这一弱势患者群体提供全球护理的改进领域。
{"title":"The Impact of RNA Polymerase III–Related Leukodystrophy on Nonaffected Family Members: A Qualitative Study","authors":"Adam Le MSc ,&nbsp;Kelly-Ann Thibault DEC ,&nbsp;Pouneh Amir Yazdani MD ,&nbsp;Alexandra Chapleau HBSc ,&nbsp;Romy J. van Voorst MSc ,&nbsp;Enrico Bertini MD ,&nbsp;Francesco Nicita MD, PhD ,&nbsp;Daniela Pohl MD, PhD ,&nbsp;Sunita Venkateswaran MD ,&nbsp;Stephanie Keller MD ,&nbsp;Deborah Renaud MD ,&nbsp;Dolores Gonzalez Moron MD, PhD ,&nbsp;Marcelo Kauffman MD, MSc, PhD ,&nbsp;Danilo De Assis Pereira MD ,&nbsp;Adeline Vanderver MD ,&nbsp;Marjo S. van der Knaap MD, PhD ,&nbsp;Maxime Morsa PhD ,&nbsp;Geneviève Bernard MD, MSc, FRCPc","doi":"10.1016/j.pediatrneurol.2025.12.004","DOIUrl":"10.1016/j.pediatrneurol.2025.12.004","url":null,"abstract":"<div><h3>Background</h3><div>RNA polymerase III–related hypomyelinating leukodystrophy (POLR3-HLD) is a rare, neurodegenerative, brain white matter disorder characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism. Due to the complex and progressive nature of this disorder, parents and siblings of patients face many potential challenges and stressors. We, therefore, sought to explore parents' and siblings’ experiences to understand their specific needs and identify modifiable factors to limit familial burden and improve their quality of life.</div></div><div><h3>Methods</h3><div>We conducted semistructured interviews with parents and siblings of patients with POLR3-HLD. Interview questions focused on the financial, emotional, and psychosocial impacts on parents, as well as siblings’ relationship with their affected sibling and the psychosocial impacts they may have experienced. All interviews were recorded, transcribed, and analyzed using reflexive thematic analysis. Through the coding process, themes surrounding the impact on and experiences of parents and siblings were developed.</div></div><div><h3>Results</h3><div>Nineteen semistructured interviews with 24 parents and nine interviews with 9 siblings were completed between March and October 2023 and February and May 2024, respectively. Four themes from parent interviews included extensive caregiver burden, emotional and psychosocial challenges, the importance of parental self-health, and comfort in the leukodystrophy community. Three themes from sibling interviews included the spectrum of emotional impacts, limited knowledge about POLR3-HLD, and adapting to their sibling's needs.</div></div><div><h3>Conclusions</h3><div>This study provides a comprehensive understanding of the family experience, identifying the common challenges and specific needs of parents and siblings, highlighting areas of improvement in the global care offered to this vulnerable patient population.</div></div>","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"176 ","pages":"Pages 31-40"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Board and Masthead 编委会和报头
IF 2.1 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-25 DOI: 10.1016/S0887-8994(26)00041-X
{"title":"Editorial Board and Masthead","authors":"","doi":"10.1016/S0887-8994(26)00041-X","DOIUrl":"10.1016/S0887-8994(26)00041-X","url":null,"abstract":"","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"176 ","pages":"Pages A1-A2"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147394802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatric neurology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1